Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision

A Nayak, S Carkaci, MZ Gilcrease, P Liu… - Clinical breast …, 2013 - Elsevier
Background The management of benign papilloma (BP) without atypia identified on breast
core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to …
被引用次数：54 相关文章

Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision

A Nayak, S Carkaci, MZ Gilcrease… - Clinical breast …, 2013 - pubmed.ncbi.nlm.nih.gov
Background The management of benign papilloma (BP) without atypia identified on breast
core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to …

Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision.

A Nayak, S Carkaci, MZ Gilcrease, P Liu… - Clinical Breast …, 2013 - europepmc.org
Background The management of benign papilloma (BP) without atypia identified on breast
core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to …

Benign Papillomas Without Atypia Diagnosed on Core Needle Biopsy: Experience From a Single Institution and Proposed Criteria for Excision

A Nayak, S Carkaci, MZ Gilcrease, P Liu… - Clinical Breast …, 2013 - infona.pl
The management of benign papilloma (BP) without atypia identified on breast core needle
biopsy (CNB) is controversial. In this study, we determined the upgrade rate to malignancy …
[HTML] nih.gov

[HTML][HTML] Benign Papillomas Without Atypia Diagnosed on Core Needle Biopsy: Experience From a Single Institution and Proposed Criteria for Excision

A Nayak, S Carkaci, MZ Gilcrease, P Liu… - Clinical breast …, 2013 - ncbi.nlm.nih.gov
The management of benign papilloma (BP) without atypia identified on breast core needle
biopsy (CNB) is controversial. We describe the clinicopathologic features of 80 patients with …
[PDF] academia.edu

[PDF][PDF] Benign Papillomas Without Atypia Diagnosed on Core Needle Biopsy: Experience From a Single Institution and Proposed Criteria for Excision

A Nayak, S Carkaci, MZ Gilcrease, P Liu… - Clinical Breast …, 2013 - academia.edu
The management of benign papilloma (BP) without atypia identified on breast core needle
biopsy (CNB) is controversial. We describe the clinicopathologic features of 80 patients with …

Benign papillomas without atypia diagnosed on core needle biopsy: Experience from a single institution and proposed criteria for excision

A Nayak, S Carkaci, MZ Gilcrease… - Clinical breast …, 2013 - mdanderson.elsevierpure.com
Background The management of benign papilloma (BP) without atypia identified on breast
core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to …

Benign papillomas without atypia diagnosed on core needle biopsy: Experience from a single institution and proposed criteria for excision

A Nayak, S Carkaci, MZ Gilcrease… - Clinical Breast …, 2013 - ohiostate.elsevierpure.com
Background The management of benign papilloma (BP) without atypia identified on breast
core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to …

Benign Papillomas Without Atypia Diagnosed on Core Needle Biopsy: Experience From a Single Institution and Proposed Criteria for Excision

A Nayak, S Carkaci, MZ Gilcrease… - Clinical Breast …, 2013 - clinical-breast-cancer.com
Background The management of benign papilloma (BP) without atypia identified on breast
core needle biopsy (CNB) is controversial. In this study, we determined the upgrade rate to …

Benign Papillomas Without Atypia Diagnosed on Core Needle Biopsy: Experience From a Single Institution and Proposed Criteria for Excision

A Nayak, S Carkaci, MZ Gilcrease, P Liu… - Clinical Breast …, 2013 - infona.pl
The management of benign papilloma (BP) without atypia identified on breast core needle
biopsy (CNB) is controversial. In this study, we determined the upgrade rate to malignancy …